N-(4-Isopropoxyphenyl)-4-{6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl}-1-piperazinecarboxamide(CAS: 387867-13-2)

This compound (CAS: 387867-13-2) falls under the control of various regulatory guidelines including the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements. Manufacturers and importers must comply with GHS for hazard communication, REACH for registration, evaluation, authorization, and restriction, and FDA/EPA for safety and environmental protection.

Several alternatives can be used in the synthesis of N-(4-Isopropoxyphenyl)-4-{6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl}-1-piperazinecarboxamide (CAS: 387867-13-2), including different piperidine derivatives and quinazoline analogs. Common alternatives include isomers with similar functional groups, and reagents such as 3-(1-piperidinyl)-1-propanol and methoxy derivatives of quinazolines.

The market for N-(4-Isopropoxyphenyl)-4-{6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl}-1-piperazinecarboxamide (CAS: 387867-13-2) is primarily driven by its use in pharmaceuticals and research. Recent trends indicate a growing interest in its applications for treating certain neurological conditions and as a potential therapeutic agent. Research trends focus on understanding its pharmacological properties and expanding its utility in various medical fields.

Waste containing N-(4-Isopropoxyphenyl)-4-{6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl}-1-piperazinecarboxamide (CAS: 387867-13-2) should be collected in appropriate containers and disposed of through incineration or professional waste disposal services. Environmental protection measures include ensuring proper containment to prevent contamination, and adherence to local and national regulations for hazardous waste management. Safe handling and disposal practices are crucial to avoid environmental and health risks.